Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (1) | Back to Search
Investigation on in vitro metabolisms of peptide drug lxt-101 and its structural modified analogs
- In: SIG Bioavailability/Bioequivalence - Posters
- At: Beijing (China) (2007)
- Type: Poster
- Poster code: BB-P-032
- By: SUN, Huixian (Institute of Pharmacology and Toxicology, Beijing, China)
- Co-author(s): GUO, Lei (Institute of Pharmacology and Toxicology, BEIJING, China)
ZHOU, Ning (Institute of Pharmacology and Toxicology, BEIJING, China)
XIE, Jian-wei (Institute of Pharmacology and Toxicology, BEIJING, China)
LIU, Ke-liang (Institute of Pharmacology and Toxicology, BEIJING, China) - Abstract:
OBJECTIVE In recent years, peptide drug has raised its wide applications in therapy based on its important functions on maintaining normal physical metabolism. For example, luteinizing hormone-releasing hormone(LHRH) is a small polypeptide with 10 amino acids, it has been employed to treat the diseases related to follicle-stimulating hormone(FSH)..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023